Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ICCC vs IG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ICCC Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–2 Matrix Metrics)

ICCC Overall Winner 6-Pillar Tally: ICCC 5 – 0 IG (1 Tie) Matrix Metrics: ICCC 7 – 2 IG

As of Nov 16, 2026, Immucell Corp (ICCC) is the stronger overall head-to-head candidate over Principal Investment Grade Corporate Active ETF (IG) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ICCC carries a Unified Composite Score of 43.8/100 (HOLD) at $11.42 (N/M Forward P/E, 15.2% operating margin), whereas IG carries 45.4/100 (HOLD) at $19.61 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While IG currently prints a higher short-term Unified Composite Score (45.4/100 HOLD vs. ICCC 43.8/100 HOLD), ICCC captures the overall institutional head-to-head verdict (7–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (15.2% vs. N/A operating margin) and revenue trajectory (+11.5% vs. N/A YoY).
  • Technical & Structure Timing Caution: ICCC trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 67.5); meanwhile IG is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 39.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ICCC vs IG
ICCC NASDAQ Head-to-Head Winner
Immucell Corp
In Vitro & In Vivo Diagnostic Substances
$11.42
+6.23% 1D
Market Cap $97.7M
TTM Revenue $67M
Forward P/E N/M
Beta / 30D Vol 0.24β · 46% Vol
Unified Composite Score
43.8 / 100 HOLD
Tech 15.0 Fund 48.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.9% over 20 days), RSI 68
RSI-14: 67.5 · SMA20: $10.37 · SMA50: $10.13
IG NYSE Arca
Principal Investment Grade Corporate Active ETF
Institutional Equity
$19.61
-0.02% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.18β · 7% Vol
Unified Composite Score
45.4 / 100 HOLD
Tech 49.0 Fund 53.0 Flow 50.0 Mom 46.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.8%) with fading momentum, RSI 39
RSI-14: 39.4 · SMA20: $19.78 · SMA50: $19.77

6-Pillar Scorecard Institutional Category Breakdown (ICCC 5 – 0 IG)

Columns: Metric · ICCC · IG
1. Valuation Multiples ICCC
Forward P/E N/M N/M
Trailing P/E 56.6x N/M
PEG Ratio N/M N/M
EV / Revenue 1.6x N/M
2. Growth & Scale ICCC
Revenue Growth (YoY) +11.5% N/A
Earnings Growth (YoY) +259.9% N/A
TTM Revenue (USD) $67M N/A
Market Cap $97.7M N/A
3. Profitability & Quality ICCC
Gross Margin 40.3% N/A
Operating Margin 15.2% N/A
Net Profit Margin 2.6% N/A
Return on Equity (ROE) 2.6% N/A
4. Balance Sheet & Cash Flow ICCC
Cash Generation (TTM) $7.4M N/A
Cash Flow Margin 11.0% N/A
Net Cash / Leverage $13M Net Debt (0.44x D/E) N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Distribution
6. R&D & Supply-Chain Moat ICCC
OpEx & R&D Intensity 25.1% of Rev ($17M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ICCC (7) vs IG (2)
Institutional Metric ICCC IG Criterion Row Edge
Market Capitalization
Scale
$97.7M N/A Larger Scale ICCC
Trailing P/E Ratio
Valuation
56.6x N/M Lower Multiple ICCC
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+11.5% N/A Higher Growth ICCC
Operating Margin (TTM)
Profitability
15.2% N/A Higher Margin ICCC
Net Profit Margin
Profitability
2.6% N/A Higher Margin ICCC
Return on Equity (ROE)
Capital Efficiency
2.6% N/A Higher ROE ICCC
52-Week Range Position
Momentum
91% ($5–$12) 14% ($19–$21) Stronger Trend ICCC
Beta / 30D Volatility
Risk Regime
0.24β · 46% Vol 0.18β · 7% Vol Lower Realized Risk IG
Unified Institutional Score
Composite Signal
43.8 / 100 (HOLD) 45.4 / 100 (HOLD) Higher Composite IG
Trailing 12M Revenue (USD)
Operating Scale
$67M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
40.3% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.6x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$7.4M ($13M Net Debt (0.44x D/E)) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ICCC +6.84 pp
ICCC: +6.23% · IG: -0.61%
3M Horizon ICCC +19.79 pp
ICCC: +17.01% · IG: -2.78%
6M Horizon ICCC +19.23 pp
ICCC: +15.24% · IG: -3.99%
1Y Horizon ICCC +94.9 pp
ICCC: +88.76% · IG: -6.14%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ICCC vs IG. Trailing 12-month operating profitability (ICCC 15.2% vs IG N/A) and valuation multiples (ICCC N/M vs IG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ICCC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$67M
Gross Margin40.3%
Op. Margin15.2%
ROE / Fwd P/E2.6% · N/M
IG ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ICCC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ICCC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ICCC Moat Profile Scale & Operating Efficiency Moat
Biotechnology Operator
Competes within the Biotechnology value chain with $97.7M market capitalization and 15.2% operating margin.
OpEx & R&D Reinvestment 25.1% of Rev ($17M)
90D Engineering Disclosures 0 Published
IG Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ICCC vs IG Key Questions & Quantitative Answers

As of Nov 16, 2026, Immucell Corp (ICCC) is the stronger overall head-to-head candidate over Principal Investment Grade Corporate Active ETF (IG) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ICCC carries a Unified Composite Score of 43.8/100 (HOLD) at $11.42 (N/M Forward P/E, 15.2% operating margin), whereas IG carries 45.4/100 (HOLD) at $19.61 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While IG currently prints a higher short-term Unified Composite Score (45.4/100 HOLD vs. ICCC 43.8/100 HOLD), ICCC captures the overall institutional head-to-head verdict (7–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (15.2% vs. N/A operating margin) and revenue trajectory (+11.5% vs. N/A YoY). Technical & Structure Timing Caution: ICCC trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 67.5); meanwhile IG is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 39.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ICCC leads the Growth & Scale pillar: ICCC posts +11.5% YoY revenue growth and +259.9% YoY earnings growth on $67M TTM revenue (40.3% gross margin, 15.2% operating margin), compared with IG at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ICCC generates $67M in USD-normalized revenue versus N/A for IG. In operating R&D and SG&A reinvestment, ICCC deploys 25.1% of Rev ($17M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IG.

ICCC screens cheaper on headline valuation multiples. ICCC trades at N/M Forward P/E, 56.6x Trailing P/E, N/M PEG, and 1.6x EV/Revenue (11.0% FCF margin), whereas IG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ICCC (2.6% ROE) versus IG (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, ICCC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.24β · 46% Vol realized risk). By comparison, IG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.18β · 7% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.